COVID-19 Vaccine Providers Newsletter 11.03.2021

  • New: FDA authorized the Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5–11 years old. Wave 1 vaccine orders will begin to ship with expected delivery Nov 1-2. Please coordinate coverage to receive vaccine Nov. 2 if you are expecting Wave 1 vaccine. As of November 2, FDA has authorized and CDC has recommended these vaccines, and administration can begin immediately in the 5–11 year old age group.
  • Allocation
    • Starting for the request period on 11/4, the Pfizer pediatric vaccine for 5 - 11 year olds will be available to request in Vaxmax. The minimum shipment quantity is 100 doses. We are working to implement these doses into the SSRP program, but that won't be available for the first few weeks.
    • Important Note on Requesting Pfizer 5 - 11: Requesting doses does not guarantee that you will have your request fulfilled. However, doses are continuing to be allocated each week, and we are confident there will be enough doses for everyone.
  • Expiration Dates
    • It's come to our attention that the doses do not have the expiration date listed on the vial. However, it does have the Manufactured date, which shouldn't be confused with the expiration date.
    • When you receive the vaccine, the doses should come with a packing label that has the expiration date listed in the bottom right corner. If you have already discarded the packing label, please refer to the Fact Sheet to determine the dose's expiration date based on the manufactured date.

For any questions about VaxMaX and its functionality, please visit the VaxMaX help website as a resource for reference guides and tutorial videos.

Best Practice Spotlight

  • VDH has published the "Vaccination of the School-Age Population in a School Setting and in the Community: Playbook to Support Vaccination Events," which can be accessed here. The playbook covers pre-planning steps, necessary communications, mapped out day-of operations, and important legal considerations. Templates for consent forms and communications, in addition to additional tools and helpful links, can also be found in the playbook. Please note that this playbook is a work in progress and will be updated in accordance with guidance from the CDC and feedback from clinic planners.

Upcoming Events

  • The Centers for Disease Control and Prevention will provide an overview of its recommendations and clinical considerations for administering the Pfizer BioNTech COVID-19 vaccination primary series in children aged 5–11 years old.
    • November 4 at 2:00 pm - 3:00 pm
      • To join: Webinar link
      • Join by Phone: 1-669-254-5252 or 1-646-828-7666
      • Webinar ID: 161 004 6996
      • Passcode: 767827
  • The VDH Vaccine Unit is offering Lunch and Learn sessions for vaccine providers to hear the latest information and answer questions of VDH Vaccine Task Force members. The following sessions are scheduled:.
    • November 5 at 12:00 pm– 1:00 pm
      • To join: Webinar Link
      • Meeting (access number):  2631 647 9131
      • Meeting Password: PXvXeVtG265
      • Join by Phone: 1-844-992-4726,, 2636479131## (toll free)
  • Pfizer Vaccines US Medical Affairs will be hosting Immunization Site Training Sessions for All Providers on the Storage, Handling, & Administration for Current & Potential New Formulations of its COVID-19 vaccine (with its partner BioNTech). These sessions will be updated to reflect new information and changes as they evolve. Such updates will be identified at the start of each session and further explained during each presentation. Please click on the links below to join the sessions at the designated times.
    • November 4 at 12:00 pm ET
  • Join Moderna for a webinar for vaccination providers to learn more about the Moderna COVID-19 Vaccine booster dose, which has been authorized for emergency use in the United States. There will be no continuing education offered for this webinar. Please register at the link below for one of our available sessions.
    • Webinar: Important updates on the mRNA-1273 50 µg Booster Dose

Webinar: Aligning Public Health and Businesses: Effective Partnerships and COVID-19 Messaging Strategies [Link]Join us on Tuesday, November 16 from 1-2 p.m. ET for a free webinar for public health communicators with timely advice on how to partner with your local business community on messaging for the upcoming holiday season and ongoing COVID-19 communications. This webinar will offer insights, practical tips, and case studies from both the public health and business perspective, with lessons learned from the pandemic that can serve public health communications now and in the future.Featured speakers: Nafissa Cisse Egbuonye, Ph.D., MPH, public health director, Black Hawk County Health Department, Iowa Stephen Massey, Co-Founder of Meteorite and Managing Director of the Health Action Alliance. The webinar will be moderated by Dr. J. Nadine Gracia, president and CEO of Trust for America’s Health.Register here.


Helpful Resources

  • New: The VDH Adult and Adolescent COVID-19 Vaccine Dosage and Scheduling Table has been added to the VDH vaccine healthcare professionals page.
  • Do I need a COVID-19 additional primary dose or booster vaccine flow chart
  • We have been alerted to a problem regarding imported medical gloves. Visit FDA’s website for more information and to learn how to report problems with medical gloves.
  • Updated: VDH’s Current COVID-19 Topics website is updated with information for the general public about vaccines for 5–11 year olds and booster doses for certain populations.
  • Updated: VDH:  When to End Isolation or Quarantine Infographic:Page 3: In the "Who is Not Required to Quarantine After Exposure" section, changed the recommended time frame for testing after exposure for fully vaccinated people from 3–5 days to 5–7 days in line with updated CDC guidance. Removed the "Critical Infrastructure Workers" section and removed reference to CDC's Critical Workers Exposed to COVID-19 at the bottom of the page.Added a summary of changes on page 4.
  • Updated: CDC COVID-19 Communication Tools

Information about the COVID-19 vaccination program is changing frequently. This newsletter will offer regular updates to providers who have submitted an intent to vaccinate or signed the CDC provider agreement within Virginia.

VDH COVID-19 Vaccination Response: Healthcare Professionals Website